课题基金 / 基金详情

DOUBLE BLIND, PARALLEL, PLACEBO AND TRIPRO-AMYLIN EFFECT ON GLUCOSE LEVEL

DOUBLE BLIND, PARALLEL, PLACEBO AND TRIPRO-AMYLIN EFFECT ON GLUCOSE LEVEL
双盲、平行、安慰剂和三胰淀粉样蛋白对血糖水平的影响
批准号:
5219697
负责人:
ROSA G HENDLER
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

ROSA G HENDLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objectives of this study are: 1) determine effect of four dose frequency regimens of tripo-amylin versus placebo on changes in 24-hour glucose profiles obtained at placebo baseline from 24 hour glucose profiles obtained at 28 days treatment, through comparison of areas under the curve; and 2) determine the safety of four dose frequency regimens of tripro-amylin versus placebo when administered by subcutaneous injection. Seven patients completed the study. The data are being analyzed by Amylin Pharmaceutical , Inc.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SIX MONTH PHASE II TRIAL OF PIOGLITAZONE GROUP IN NIDDM PATIENTS
  • 批准号:
    6306202
  • 项目类别:
  • 资助金额:
    $3.45万
  • 财政年份:
    1999
  • 负责人:
    ROSA G HENDLER
  • 依托单位:
SIX MONTH PHASE II TRIAL OF PIOGLITAZONE GROUP IN NIDDM PATIENTS
  • 批准号:
    6116033
  • 项目类别:
  • 资助金额:
    $3.45万
  • 财政年份:
    1998
  • 负责人:
    ROSA G HENDLER
  • 依托单位:
METABOLIC RATE AND PROTEIN, CARBOHYDRATE AND LIPID METABOLISM IN OBESITY
  • 批准号:
    6115992
  • 项目类别:
  • 资助金额:
    $3.45万
  • 财政年份:
    1998
  • 负责人:
    ROSA G HENDLER
  • 依托单位:
EFFECTS OF ACARBOSE IN GLYCEMIC & LIPID CONTROL IN IDDM PATIENTS (TYP
  • 批准号:
    6264711
  • 项目类别:
  • 资助金额:
    $3.45万
  • 财政年份:
    1998
  • 负责人:
    ROSA G HENDLER
  • 依托单位:
海外基金